Literature DB >> 29582440

A preclinical Talbot-Lau prototype for x-ray dark-field imaging of human-sized objects.

C Hauke1,2, P Bartl1, M Leghissa1, L Ritschl1, S M Sutter1, T Weber1, J Zeidler1, J Freudenberger1, T Mertelmeier1, M Radicke1, T Michel2, G Anton2, F G Meinel3, A Baehr4, S Auweter5, D Bondesson5, T Gaass5, J Dinkel5, M Reiser5, K Hellbach5.   

Abstract

PURPOSE: Talbot-Lau x-ray interferometry provides information about the scattering and refractive properties of an object - in addition to the object's attenuation features. Until recently, this method was ineligible for imaging human-sized objects as it is challenging to adapt Talbot-Lau interferometers (TLIs) to the relevant x-ray energy ranges. In this work, we present a preclinical Talbot-Lau prototype capable of imaging human-sized objects with proper image quality at clinically acceptable dose levels.
METHODS: The TLI is designed to match a setup of clinical relevance as closely as possible. The system provides a scan range of 120 × 30 cm2 by using a scanning beam geometry. Its ultimate load is 100 kg. High aspect ratios and fine grid periods of the gratings ensure a reasonable setup length and clinically relevant image quality. The system is installed in a university hospital and is, therefore, exposed to the external influences of a clinical environment. To demonstrate the system's capabilities, a full-body scan of a euthanized pig was performed. In addition, freshly excised porcine lungs with an extrinsically provoked pneumothorax were mounted into a human thorax phantom and examined with the prototype.
RESULTS: Both examination sequences resulted in clinically relevant image quality - even in the case of a skin entrance air kerma of only 0.3 mGy which is in the range of human thoracic imaging. The presented case of a pneumothorax and a reader study showed that the prototype's dark-field images provide added value for pulmonary diagnosis.
CONCLUSION: We demonstrated that a dedicated design of a Talbot-Lau interferometer can be applied to medical imaging by constructing a preclinical Talbot-Lau prototype. We experienced that the system is feasible for imaging human-sized objects and the phase-stepping approach is suitable for clinical practice. Hence, we conclude that Talbot-Lau x-ray imaging has potential for clinical use and enhances the diagnostic power of medical x-ray imaging.
© 2018 American Association of Physicists in Medicine.

Entities:  

Keywords:  Talbot-Lau interferometer; radiography; x-ray dark-field imaging; x-ray interferometry

Mesh:

Year:  2018        PMID: 29582440     DOI: 10.1002/mp.12889

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  4 in total

1.  Imaging characteristics of intravascular spherical contrast agents for grating-based x-ray dark-field imaging - effects of concentrations, spherical sizes and applied voltage.

Authors:  Susan Notohamiprodjo; Karla Maria Treitl; Christian Hauke; Sven-Martin Sutter; Sigrid Auweter; Franz Pfeiffer; Maximilian Ferdinand Reiser; Katharina Hellbach
Journal:  Sci Rep       Date:  2020-06-10       Impact factor: 4.379

2.  Whole-body x-ray dark-field radiography of a human cadaver.

Authors:  Jana Andrejewski; Fabio De Marco; Konstantin Willer; Wolfgang Noichl; Alex Gustschin; Thomas Koehler; Pascal Meyer; Fabian Kriner; Florian Fischer; Christian Braun; Alexander A Fingerle; Julia Herzen; Franz Pfeiffer; Daniela Pfeiffer
Journal:  Eur Radiol Exp       Date:  2021-01-26

3.  Fabrication of X-ray absorption gratings by centrifugal deposition of bimodal tungsten particles in high aspect ratio silicon templates.

Authors:  Simon Pinzek; Alex Gustschin; Nikolai Gustschin; Manuel Viermetz; Franz Pfeiffer
Journal:  Sci Rep       Date:  2022-03-30       Impact factor: 4.379

4.  Retrieval of 3D information in X-ray dark-field imaging with a large field of view.

Authors:  Jana Andrejewski; Fabio De Marco; Konstantin Willer; Wolfgang Noichl; Theresa Urban; Manuela Frank; Alex Gustschin; Pascal Meyer; Thomas Koehler; Franz Pfeiffer; Julia Herzen
Journal:  Sci Rep       Date:  2021-12-06       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.